spacer
home > ebr > summer 2003 > fighting sars in the post-genomic era
PUBLICATIONS
European Biopharmaceutical Review

Fighting SARS in the Post-Genomic Era

Severe acute respiratory syndrome (SARS) has spread rapidly from its likely site of origin in Southern China to a large number of countries throughout the world. Initial symptoms of the disease include high fever, malaise, rigor, headache and a non-productive cough, and can later progress to generalised interstitial infiltrates in the lung, requiring intubation and mechanical ventilation. The mortality rate among patients meeting the current case definition of SARS is approximately 15 per cent, while it can reach 50 per cent for patients who are 60 years of age or older (1). Epidemiological evidence suggests that the transmission of this newly emerging pathogen occurs mainly through close contact, although other routes of transmission cannot be excluded. At the time of writing more than 8,000 SARS cases had been diagnosed in 28 countries or regions, with the numbers still rising. At present, neither reliable early diagnosis nor efficacious treatment are available.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Professor Yike Guo, Technical Director of the Parallel Computing Centre and Head of the Data Mining Group of Imperial College, and Dr Wayne He, Director of SCBIT-IBM-InforSense Joint Laboratory of the Shanghai Center for Bioinformation Technology (SCBIT)

Professor Yike Guo (seated) is a leading researcher in Computing Science at Imperial College, London. He serves as Technical Director of the Parallel Computing Centre of Imperial College, and Head of the Data Mining Group of the university. Professor Guo is also the Founder and CEO of InforSense, a software company for life science informatics. His research focuses on parallel applications and network computing, including parallel data mining algorithms, distributed data mining systems, decision support systems and parallel symbolic computation. Professor Guo leads a large research group to develop new technology and software systems for large-scale integrated data analysis focusing on life science discovery.

Dr Wayne He (standing) is the director of SCBIT-IBM-InforSense Joint Laboratory of the Shanghai Center for Bioinformation Technology (SCBIT). Before joining SCBIT, he was a Senior Biomedical Engineer at Incyte Pharmaceuticals, Inc where he led the development of LifeSeq Gold online. Dr He received his PhD in Biochemistry from Imperial College, London, and was a visiting scientist at the University of California at Berkeley before joining Incyte.

spacer
Professor Yike Guo
spacer
spacer
spacer
Dr Wayne He
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

AirBridgeCargo expands its passive pharma solutions in partnership with SkyCell as it achieves the two-fold volume increase

AirBridgeCargo expands its passive pharma solutions in partnership with SkyCell as it achieves the two-fold volume increase AirBridgeCargo Airlines (ABC), one of the leaders in transportation of pharmaceutical products by air, and Zurich-based cold-chain ULD manufacturer SkyCell have sealed their partnership for the lease of all types of SkyCell containers to meet the demand for evolving volumes of passive pharmaceutical shipments, which reached around 3,500 tonnes for 1Q 2019 YOY and demonstrated a two-fold increase.
More info >>

White Papers

PROTEIN:PROTEIN INTERACTION ANALYSIS

IBA GmbH

Groth et al., 2007 and Jasencakova et al., 2010 Protein:protein-interactions (PPI) govern almost all important processes in living organisms. Thus, their rapid and accurate determination and investigation is a major challenge in life sciences. The extremely efficient and fast One-STrEP (Twin-Strep) system is suitable for the isolation of functional protein complexes and subsequent mass spectrometry analysis leads to the identification of protein complex components (Junttila et al., 2005) as it is shown in the following studies.
More info >>

 
Industry Events

World Vaccine Congress Europe

28-31 October 2019, Barcelona, Spain

The 20th annual World Vaccine Congress Europe is taking place 28-31 Oct in Barcelona. It’s the biggest and most established European vaccine event with over 250 speakers, 700+ senior vaccine attendees, hundreds of networking hours. It cover key topics across the complete vaccine value chain bringing together: • Government • big pharma • big biotech • SME Biotech • academia and the wider service provider community and their partners to discuss scientific, clinical and strategic advances and opportunities. The event has already confirmed over 200 speakers from Human Vaccine Project, OECD, CEPI, European Commission, FDA, WHO, OECD, NIH, GSK and many more… There is a Super Early Bird offer available – Find Out More www.terrapinn.com/WVCEU/EBR
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement